Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.70
Ask:
2.00
Spread: 0.30 (17.647%)
Market Cap: £8.08m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director Dealing

19 Dec 2018 18:28

RNS Number : 0427L
Renalytix AI PLC
19 December 2018
 

 

Renalytix AI plc

 

("RenalytixAI" or the "Company") 

 

 

Director Dealing

 

 

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.

 

Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.

 

Enquiries:

 

Renalytix AI plc

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR or

Tel: +1 646 397 3970

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / James White / George Tzimas (Corporate Finance)

Tom Salvesen / Mia Gardner (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780

or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

 

 

 

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Harwood Capital LLP (Harwood) as investment manager to NASCIT

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Renalytix AI Plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

Identification code

GB00BYWL4Y04

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

103 pence

5,970

 

 

 

 

 

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

19 December 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKCDBFBDDQBD
Date   Source Headline
4th Nov 20245:42 pmRNSHolding(s) in Company
31st Oct 20243:10 pmRNSDirectorate Change
31st Oct 20242:10 pmRNSResult of General Meeting
11th Oct 20244:55 pmRNSPosting of Circular & Notice of GM
11th Oct 20247:02 amRNSDirector/PDMR Shareholding
11th Oct 20247:01 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSHolding(s) in Company
9th Oct 20244:40 pmRNSHolding(s) in Company
8th Oct 20241:55 pmRNSAdmission of Shares & Total Voting Rights
8th Oct 20247:00 amRNSCommencement of trading on OTCQB in the US
1st Oct 202412:02 pmRNSResult of Placing and Subscription
1st Oct 20247:00 amRNSAudited US GAAP financial results
30th Sep 20245:42 pmRNSPlacing and Subscription
30th Sep 20245:41 pmRNSRe. Results for the fiscal year ended 30 June '24
30th Aug 20247:00 amRNSChange of Adviser
30th Aug 20247:00 amRNSTotal Voting Rights
27th Aug 20249:30 amRNSNasdaq Grants Listing Extension
21st Aug 20247:00 amRNSAppointment of Joint Corporate Broker
20th Aug 20247:00 amRNSTermination of Formal Sale Process
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
14th Aug 20249:47 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
7th Aug 20249:09 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
6th Aug 20249:42 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
5th Aug 20249:36 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
2nd Aug 202410:21 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
1st Aug 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
31st Jul 20249:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
30th Jul 20249:46 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20247:57 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
16th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
16th Jul 20247:46 amGNWForm 8.5 (EPT/RI)-Renalytix plc
15th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Jul 20247:00 amRNSIssue of Shares and Rule 2.9 Announcement
12th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
12th Jul 20249:05 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
11th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
11th Jul 20247:00 amRNSSteno Diabetes Center (Copenhagen) Collaboration
10th Jul 20243:26 pmRNSHolding(s) in Company
10th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202410:01 amRNSForm 8.5 (EPT/RI) - Renalytix plc - Amendment
2nd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.